多重用药与养老院居民1年内认知和躯体功能轨迹的关联:欧洲多中心研究
调整混杂因素后,多重用药和过度多重用药均与CPS评分下降显著相关,但与ADL评分变化无统计学显著关联。
要点
- 养老院居民中多重用药(5-9种)占50%,过度多重用药(≥10种)占24%。
- 多重用药与过度多重用药均与1年内认知功能(CPS)下降显著相关。
核心结论
- 多重用药在养老院老年居民中高度普遍,且1年内与认知功能恶化相关,但与躯体功能下降无关。
研究设计与样本
- 基于SHELTER研究的纵向多中心队列研究,纳入欧洲50家和以色列7家养老院的3234名老年居民,使用interRAI长期照护机构评估工具,通过线性混合模型分析多重用药与时间交互作用。
主要发现
- 1630名(50%)居民存在多重用药(5-9种药物),781名(24%)存在过度多重用药(≥10种药物)。
- 调整潜在混杂因素后,多重用药者CPS评分下降显著高于使用<5种药物者(beta 0.10,95%CI 0.01-0.20)。
- 过度多重用药者CPS评分下降亦显著更高(beta 0.13,95%CI 0.01-0.24)。
关键数值与推荐
- 多重用药定义为同时使用5至9种药物,过度多重用药定义为使用≥10种药物。
- 认知功能采用认知表现量表(CPS)评估,功能状态采用日常生活活动能力(ADL)等级量表评估。
临床怎么用
- 对养老院老年居民应关注多重用药状态,尤其使用≥10种药物者,需监测认知功能变化。
- 多重用药与认知下降相关,提示在老年综合评估中应纳入用药审查并考虑认知保护策略。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To test the association between polypharmacy and 1-year change in physical and cognitive function among nursing home (NH) residents. DESIGN: Longitudinal multicenter cohort study based on data from the Services and Health for Elderly in Long TERm care (SHELTER) study. SETTING: NH in Europe (n = 50) and Israel (n = 7). PARTICIPANTS: 3234 NH older residents. MEASUREMENTS: Participants were assessed through the interRAI long-term care facility instrument. Polypharmacy was defined as the concurrent use of 5 to 9 drugs and excessive polypharmacy as the use of ≥10 drugs. Cognitive function was assessed through the Cognitive Performance Scale (CPS). Functional status was evaluated through the Activities of Daily Living (ADL) Hierarchy scale. The change in CPS and ADL score, based on repeated assessments, was the outcome, and their association with polypharmacy was modeled via linear mixed models. The interaction between polypharmacy and time was reported [beta and 95% confidence intervals (95% CIs)]. RESULTS: A total of 1630 (50%) residents presented with polypharmacy and 781 (24%) excessive polypharmacy. After adjusting for potential confounders, residents on polypharmacy (beta 0.10, 95% CI 0.01-0.20) and those on excessive polypharmacy (beta 0.13, 95% CI 0.01-0.24) had a significantly higher decline in CPS score compared to those using <5 drugs. No statistically (P > .05) significant change according to polypharmacy status was shown for ADL score. CONCLUSIONS: Polypharmacy is highly prevalent among older NH residents and, over 1 year, it is associated with worsening cognitive function but not functional decline.
引用
- Vetrano DL, Villani ER, Grande G, et al. Association of Polypharmacy With 1-Year Trajectories of Cognitive and Physical Function in Nursing Home Residents: Results From a Multicenter European Study. J Am Med Dir Assoc. 2018. PMID: 29861194. doi:10.1016/j.jamda.2018.04.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。